LOUISVILLE, Ky., Sept. 24, 2025 /PRNewswire/ -- Cognision, a leader in high-performance neurophysiological biomarker solutions and services, has announced a strategic partnership with SOMNOmedics AG, ...
LOUISVILLE, Ky., Nov. 14, 2025 /PRNewswire/ -- Cognision, provider of advanced neurobiomarker technology, announces its partnership with Kynexis to utilize the COGNISION ® System in Kynexis' Phase 2 ...
Multi-site CNS clinical trials have long struggled with operational complexity. Researchers juggle disparate systems for EEG, sleep studies, eye tracking, wearable sensors, and cognitive ...
Neuronetrix today announced that it has received 510(k) clearance (K141316) from the United States Food and Drug Administration to market the COGNISION™ System for clinical use. The COGNISION™ System ...
LOUISVILLE, Ky.--(BUSINESS WIRE)--The ERP Biomarker Qualification Consortium was launched today by pharmaceutical industry members with the goal of qualifying event-related potential (ERP) biomarkers ...
K.C. Fadem, founder, president and CEO of Neuronetrix Inc., is shown with three versions of the company's Cognision System, which measures brain activity. The unit on the right is the earliest version ...
The partnership leverages Cognision's expertise in providing complex neurophysiological assessments in regulated research environments with SOMNOmedics' proven compact, mobile, and full-featured PSG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results